50% off Premium Yearly
Agilent TechnologiesABUYFeb 11, 2001Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
Is up 55% from its April lows. They just reported a strong quarter with 7% organic growth. The business is turning around, helped by re-shoring in life sciences, plus the rise of some medicine that require more hardware to produce. The FDA is less disruptive as expected. The life sciences sector looks attractive.